GlassScriptPhysician profile
Cicely Anne Dye
NPI 1750519443
$53,915.93
in general payments reported to CMS, 2019-2025
13 companies · $2,872 in 2025
The $2,872 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $20K · 2022: $18K · 2023: $7,251 · 2024: $6,240 · 2025: $2,872.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,315 · Travel and Lodging: $6,448 · Consulting Fee: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,314.72 |
| Travel and Lodging | $6,448.05 |
| Consulting Fee | $600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $20,103.90 | 2021-2025 | Selectsecure, Micra, Aurora Ev-Icd Mri Surescan |
| Boston Scientific Corporation | $15,228.64 | 2021-2025 | General - Therapies, Accolade Sr, Wolverine Coronary Cutting Balloon |
| Abbott Laboratories | $8,607.03 | 2021-2025 | Ensite Precision, Aveir, Ensite |
| Biotronik INC. | $5,912.80 | 2021-2025 | Biomonitor, Renamic Neo, Amvia Edge |
| Medical Device Business Services, INC. | $2,646.79 | 2022-2023 | Carto 3 |
| Cardiofocus, INC. | $549.62 | 2023-2024 | Heartlight System |
| Baylis Medical Company INC | $399.54 | 2021 | |
| Philips North America LLC | $242.00 | 2021-2025 | Igt Devices Undivided |
| Biosense Webster, INC. | $154.77 | 2021-2023 | Carto 3 |
| Cardiva Medical, INC. | $20.61 | 2024 | Esophageal Cooling Device |
| Novartis Pharmaceuticals Corporation | $17.99 | 2025 | |
| Cordis US Corp. | $17.25 | 2025 | Mynx Control |
| Bracco Diagnostics INC. | $14.99 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cicely Dye listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.